ATLANTA – Susan Schneider Williams shares “three overlooked ideas in this disease space.”
The agency’s approval of Dsuvia comes at a time when the need is great for nonaddictive agents for pain control.
The opioid is to used for only adult patients in settings that are closely controlled.
Topics include: Short-term NSAID use • chronic liver disease & pneumonia • Antibiotic prescribing • fractures in older men • ART for younger...
News from the FDA/CDC
The central nervous system depressant was approved for the treatment of cataplexy and excessive daytime sleepiness.
SAN DIEGO – Vascular disease, especially of the small blood vessels, may be a culprit.
ATLANTA – The prolonged period of heightened risk was evident in patients with both STEMI and NSTEMI.
NEW YORK – Pilot studies of a standardized stimulation technique show promising clinical results backed by fMRI...
BERLIN – Smokers took a “clinically significant” cognitive hit, however.
BERLIN – Men with MS and either depression or bipolar disorder were at especially higher risk of worsening disability.